Novel Pediatric Sepsis Criteria and Clinical Decision Support Tools
新型儿科败血症标准和临床决策支持工具
基本信息
- 批准号:10280004
- 负责人:
- 金额:$ 75.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAddressAdultAdvisory CommitteesAffectBangladeshCaringCessation of lifeChildChildhoodChinaClinicalClinical DataColombiaCritical CareCritically ill childrenDataDatabasesDevelopmentDiagnosisDiseaseEarly DiagnosisEarly identificationElectronic Health RecordEmergency CareEnvironmentFunctional disorderHealth PrioritiesHeartHospital MortalityHuman bodyImmune responseIncomeInfectionInpatientsInstitutionIntensive Care UnitsInternationalKidneyLifeLungMeasurementMeasuresMedicineModelingOrganOrgan failurePatientsPediatric HospitalsPublic HealthPublishingResourcesRoleScienceSepsisSiteSocietiesSpecificitySystemSystemic Inflammatory Response SyndromeTechniquesUpdateWorkbaseclinical careclinical decision supportcomputing resourcesdata resourcedesigneffective therapyglobal healthhealth care availabilityhigh riskimprovedimproved outcomeinnovationinpatient servicelow and middle-income countriesmobile applicationmortalitymortality risknovelpediatric emergencyprototyperesponserisk stratificationsupport toolssystemic inflammatory responseunnecessary treatment
项目摘要
PROJECT SUMMARY/ABSTRACT
Pediatric sepsis is a major global public health problem associated with millions of deaths every year. However,
the current criteria to diagnose pediatric sepsis are outdated, lack specificity, do not allow early detection and
risk stratification in all settings, and are discordant with clinician-based diagnosis. In 2016, the adult Sepsis-3
task force redefined sepsis as “life-threatening organ dysfunction caused by a dysregulated host response to
infection,” emphasizing the pivotal role of organ dysfunction in the pathophysiology of sepsis. Importantly, they
used a data-driven approach. The adult Sepsis-3 criteria, however, have been criticized for their limited
applicability outside the intensive care unit and in resource-limited settings. The pediatric criteria are still based
on the systemic inflammatory response syndrome and unvalidated organ dysfunction criteria. In 2019, the
Society of Critical Care Medicine and other major global organizations sponsored the creation of the Pediatric
Sepsis Definition Task Force to update the definition and operational criteria for pediatric sepsis. The overall
objective of this proposal is to derive and validate novel pediatric sepsis criteria that generalize beyond
the ICU and to differently resourced settings. The new criteria will be based on measures of organ
dysfunction. However, it remains unknown which organ dysfunction measures are optimal for the new pediatric
sepsis criteria. Furthermore, there is currently no pediatric emergency and inpatient database with the
granularity and broad representation needed to derive and validate the new sepsis criteria. In this proposal, we
will address these critical gaps to advance the science and clinical care of pediatric sepsis. We will extend our
prior work and leverage the expertise of our international investigative team to build a large, centralized
electronic health record database of pediatric emergency and inpatient care from institutions in both
high-income countries and low- and middle-income countries. We will use these rich clinical data to accomplish
the following aims: 1) determine the optimal clinical criteria for each pediatric organ dysfunction in differently
resourced settings and care environments, 2) develop and validate novel pediatric sepsis criteria, and 3) design,
build, and evaluate prototype CDS tools to facilitate use of the new pediatric sepsis criteria. We have assembled
an investigative team with a successful track record in the field and will work in partnership with the Pediatric
Sepsis Definition Task Force to address this global health priority. We expect the results of this proposal to have
a powerful and sustained impact on the science of pediatric sepsis and organ dysfunction and ultimately
improve sepsis recognition, accelerate appropriate effective treatment, decrease unnecessary treatment, and
improve the outcomes of children with sepsis around the world.
项目总结/摘要
小儿败血症是一个主要的全球公共卫生问题,每年有数百万人死亡。然而,在这方面,
目前诊断小儿败血症的标准已经过时,缺乏特异性,不能早期发现,
在所有情况下的风险分层,并与临床医生为基础的诊断不一致。2016年,成年败血症-3
工作组将脓毒症重新定义为“由宿主对
感染,”强调器官功能障碍在脓毒症的病理生理学中的关键作用。重要的是他们
使用了数据驱动的方法。然而,成人脓毒症-3标准因其局限性而受到批评。
在重症监护病房外和资源有限的环境中的适用性。儿科标准仍然是基于
全身炎症反应综合征和未经验证的器官功能障碍标准。2019年
重症监护医学协会和其他主要的全球组织赞助了儿科
脓毒症定义工作组将更新儿科脓毒症的定义和操作标准。整体
本提案的目的是推导和验证新的儿科脓毒症标准,
重症监护室和不同的资源设置。新的标准将基于器官的测量,
功能障碍然而,目前尚不清楚哪些器官功能障碍的措施是最佳的新的儿科
脓毒症标准。此外,目前还没有儿科急诊和住院数据库,
需要粒度和广泛的代表性来推导和验证新的脓毒症标准。在本提案中,我们
将解决这些关键的差距,以推进儿科败血症的科学和临床护理。我们将扩大我们的
利用我们的国际调查团队的专业知识,
两个地区的儿科急诊和住院医疗机构的电子健康记录数据库
高收入国家和中低收入国家。我们将利用这些丰富的临床数据,
以下目的:1)确定不同儿童器官功能障碍的最佳临床标准,
资源设置和护理环境,2)开发和验证新的儿科败血症标准,和3)设计,
构建和评估原型CDS工具,以促进新的儿科败血症标准的使用。我们已经组建
一个在该领域有成功记录的调查小组,将与儿科合作,
脓毒症定义工作组,以解决这一全球卫生优先事项。我们希望这项提案的结果
对儿科败血症和器官功能障碍的科学产生了强大而持续的影响,
提高脓毒症识别,加速适当有效治疗,减少不必要的治疗,
改善世界各地脓毒症儿童的预后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tellen Bennett其他文献
Tellen Bennett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tellen Bennett', 18)}}的其他基金
Novel Pediatric Sepsis Criteria and Clinical Decision Support Tools
新型儿科败血症标准和临床决策支持工具
- 批准号:
10478249 - 财政年份:2021
- 资助金额:
$ 75.46万 - 项目类别:
Novel Pediatric Sepsis Criteria and Clinical Decision Support Tools
新型儿科败血症标准和临床决策支持工具
- 批准号:
10684927 - 财政年份:2021
- 资助金额:
$ 75.46万 - 项目类别:
Pediatric COVID-19 Dashboard and Clinical Phenotypes
儿科 COVID-19 仪表板和临床表型
- 批准号:
10658654 - 财政年份:2021
- 资助金额:
$ 75.46万 - 项目类别:
Archiving Common Data Element-Harmonized Pediatric Traumatic Brain Injury Data and Metadata
归档通用数据元素 - 协调的儿科创伤性脑损伤数据和元数据
- 批准号:
9789058 - 财政年份:2018
- 资助金额:
$ 75.46万 - 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
- 批准号:
8579363 - 财政年份:2013
- 资助金额:
$ 75.46万 - 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
- 批准号:
8695424 - 财政年份:2013
- 资助金额:
$ 75.46万 - 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
- 批准号:
9049521 - 财政年份:2013
- 资助金额:
$ 75.46万 - 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
- 批准号:
8857351 - 财政年份:2013
- 资助金额:
$ 75.46万 - 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
- 批准号:
9263010 - 财政年份:2013
- 资助金额:
$ 75.46万 - 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
- 批准号:
8847755 - 财政年份:2013
- 资助金额:
$ 75.46万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 75.46万 - 项目类别:
Research Grant